A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination

Clinical trial NCT03858348 · COMPLETED

Trial details

NCT number: NCT03858348
Sponsor: Elpen Pharmaceutical Co. Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

COPD COPD Exacerbation

Start date: 2019-05-01
Primary completion: 2019-12-31
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.